Self-Administered Drugs Market By Product type (Injectable drugs, Inhaled drugs), Mode of administration (Oral, Transdermal, Intravenous, Nasal), Application (Diabetes, Hormone replacement, Cardiovascular ailment, Pain management, Osteoporosis, Others), Industry Trends, Estimation & Forecast, 2017 - 2025
This report studies Self-Administered Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2025.
Drugs administered by the patients without the help of medical professionals are referred to as self-administered drugs. Self-administered drugs such as topical prescription drugs, over-the-counter drugs, and self-administered intravenous drugs are mainly consumed by patients suffering from chronic diseases such as multiple sclerosis, rheumatoid arthritis, diabetes and others. The rising prevalence of chronic diseases globally is expected to boost the demand for self-administered drugs, mainly among the geriatric and working populace. As per WHO, by 2050, the world’s aged population (60 years and older) is expected to reach the 2 billion mark, up from 900 million in 2015.
The key factor driving the growth of global self-administered drugs market is the increasing outpatient services. The changing life style of people encourages them to opt for outpatient services, which in turn fuels the market growth. Moreover, the rising number of diabetic patients, and the government insurance organizations are also driving the growth of global self-administered drugs market. According to WHO, 422 million adults have diabetes worldwide. Such a huge pool of diabetic patients is expected to increase the demand for self-administered drugs. On the other hand, side effects caused due to improper dosage, along with low or zero reimbursement are hindering the market of self-administered drugs. However, innovations in medical science, and increasing awareness regarding self-administered drugs are expected to create huge opportunities for the growth of market in the upcoming years.
SELF-ADMINISTERED DRUGS MARKET SEGMENTATION
By Product Type
• Injectable drugs
• Inhaled drugs
By Mode of Administration
• Hormone replacement
• Cardiovascular ailment
• Pain management
• North America
• Rest of the World
Table of Content
• Novartis AG
• Bristol-Mayers Squibb
• Gilead Sciences
• Eli Lilly & Company
• Pfizer, Inc.
• Abbott Laboratories
• Antares Pharma, Inc.
What Information does this report contain?
• What was the market size of the Self-Administered Drugs Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Self-Administered Drugs Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?
You may also like
Aromatherapy Market by Product (Consumables, and Equipment); By Mode of Delivery (Topical Application, Aerial Diffusion, and Direct Inhalation); By Application (Relaxation, Skin & Hair Care, Pain Management, Insomnia, Cold & Cough, Scar Management, and Others); By End-Use (Home Use, Spa & Wellness Centers, Hospitals & Clinics, and Yoga & Meditation Centers); By Distribution Channel (DTC, and B2B); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026